Apex Biotechnology Corp (1733) — Cash Flow Quality Index
Apex Biotechnology Corp (1733) has a Cash Flow Quality Index of 0.18x as of September 2025. Operating cash flow of NT$5.19 Million is below net income of NT$29.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Apex Biotechnology Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apex Biotechnology Corp Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Apex Biotechnology Corp across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 1733 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Apex Biotechnology Corp (2002–2024)
Year-by-year earnings quality comparison for Apex Biotechnology Corp. For live market cap and the full company financial profile, see 1733 company net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.15x | NT$328.67 Million | NT$153.13 Million | ▲ +31.3% |
| 2023 | 1.63x | NT$230.39 Million | NT$140.96 Million | ▲ +1125.5% |
| 2022 | 0.13x | NT$26.62 Million | NT$199.57 Million | ▼ -86.3% |
| 2021 | 0.97x | NT$179.87 Million | NT$184.94 Million | ▼ -61.7% |
| 2020 | 2.54x | NT$280.60 Million | NT$110.61 Million | ▼ -10.6% |
| 2019 | 2.84x | NT$462.52 Million | NT$162.94 Million | ▲ +577.8% |
| 2018 | 0.42x | NT$67.57 Million | NT$161.34 Million | ▼ -33.8% |
| 2017 | 0.63x | NT$70.83 Million | NT$111.97 Million | ▼ -88.9% |
| 2016 | 5.72x | NT$298.06 Million | NT$52.09 Million | ▲ +277.3% |
| 2015 | 1.52x | NT$472.15 Million | NT$311.29 Million | ▲ +80.8% |
| 2014 | 0.84x | NT$267.60 Million | NT$318.94 Million | ▼ -26.2% |
| 2013 | 1.14x | NT$484.77 Million | NT$426.38 Million | ▲ +16.5% |
| 2012 | 0.98x | NT$509.67 Million | NT$522.45 Million | ▲ +87.9% |
| 2011 | 0.52x | NT$273.45 Million | NT$526.62 Million | ▼ -49.4% |
| 2010 | 1.03x | NT$465.59 Million | NT$453.95 Million | ▼ -14.4% |
| 2009 | 1.20x | NT$391.29 Million | NT$326.48 Million | ▲ +13.6% |
| 2008 | 1.06x | NT$299.96 Million | NT$284.29 Million | ▲ +16.5% |
| 2007 | 0.91x | NT$364.62 Million | NT$402.53 Million | ▼ -24.2% |
| 2006 | 1.19x | NT$363.71 Million | NT$304.41 Million | ▼ -9.5% |
| 2004 | 1.32x | NT$218.54 Million | NT$165.49 Million | ▼ -29.4% |
| 2003 | 1.87x | NT$302.25 Million | NT$161.60 Million | ▲ +137.0% |
| 2002 | 0.79x | NT$79.49 Million | NT$100.74 Million | — |